Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Giralt

Showing results (21-30 of 176) with videos related to

Pageof 18
Sort By:
Bone Marrow Transplantation|October 10, 2017
Third International workshop on the biology, prevention, and treatment of relapse after stem cell transplantationN Kröger, M Bishop, S Giralt, et al.
Hematology (Amsterdam, Netherlands)|April 29, 2010
Rapid control of previously untreated multiple myeloma with bortezomib-lenalidomide-dexamethasone (BLD)M Wang, K Delasalle, S Giralt, et al.
Current Oncology Reports|December 21, 2000
Allogeneic hematopoietic transplantation for acute and chronic myeloid leukemia: non-myeloablative preparative regimens and induction of the graft-versus-leukemia effectA Shimoni, S Giralt, I Khouri, et al.
Current Oncology Reports|December 21, 2000
Allogeneic hematopoietic transplantation for chronic lymphocytic leukemia and lymphoma: potential for nonablative preparative regimensR Champlin, van Besien K, S Giralt, et al.
Bone Marrow Transplantation|February 1, 1995
Treatment of leukemia relapse after bone marrow transplantation with interferon-alpha and interleukin 2L Shaffer, S Giralt, R Champlin, et al.
Bailliere'S Clinical Haematology|June 1, 1997
Natural history and staging of chronic myelogenous leukaemiaJ Cortes, H M Kantarjian, S Giralt, et al.
Oncology (Williston Park, N.Y.)|June 5, 1999
Reinventing bone marrow transplantation. Nonmyeloablative preparative regimens and induction of graft-vs-malignancy effectR Champlin, I Khouri, S Komblau, et al.
Current Opinion in Oncology|November 21, 2000
Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic stem cell transplantationD R Couriel, K Hicks, S Giralt, et al.
Current Opinion in Oncology|April 3, 1999
Reinventing bone marrow transplantation: reducing toxicity using nonmyeloablative, preparative regimens and induction of graft-versus-malignancyR Champlin, I Khouri, S Kornblau, et al.
Leukemia & Lymphoma|August 1, 1994
Leukemia cutis in acute promyelocytic leukemia: report of three cases after treatment with all-trans retinoic acidS Giralt, S O'Brien, E Weeks, et al.
Pageof 18

Showing results (21-30 of 176) with videos related to

Sort By:
Pageof 18
Bone Marrow Transplantation|October 10, 2017
Third International workshop on the biology, prevention, and treatment of relapse after stem cell transplantationN Kröger, M Bishop, S Giralt, et al.
Hematology (Amsterdam, Netherlands)|April 29, 2010
Rapid control of previously untreated multiple myeloma with bortezomib-lenalidomide-dexamethasone (BLD)M Wang, K Delasalle, S Giralt, et al.
Current Oncology Reports|December 21, 2000
Allogeneic hematopoietic transplantation for acute and chronic myeloid leukemia: non-myeloablative preparative regimens and induction of the graft-versus-leukemia effectA Shimoni, S Giralt, I Khouri, et al.
Current Oncology Reports|December 21, 2000
Allogeneic hematopoietic transplantation for chronic lymphocytic leukemia and lymphoma: potential for nonablative preparative regimensR Champlin, van Besien K, S Giralt, et al.
Bone Marrow Transplantation|February 1, 1995
Treatment of leukemia relapse after bone marrow transplantation with interferon-alpha and interleukin 2L Shaffer, S Giralt, R Champlin, et al.
Bailliere'S Clinical Haematology|June 1, 1997
Natural history and staging of chronic myelogenous leukaemiaJ Cortes, H M Kantarjian, S Giralt, et al.
Oncology (Williston Park, N.Y.)|June 5, 1999
Reinventing bone marrow transplantation. Nonmyeloablative preparative regimens and induction of graft-vs-malignancy effectR Champlin, I Khouri, S Komblau, et al.
Current Opinion in Oncology|November 21, 2000
Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic stem cell transplantationD R Couriel, K Hicks, S Giralt, et al.
Current Opinion in Oncology|April 3, 1999
Reinventing bone marrow transplantation: reducing toxicity using nonmyeloablative, preparative regimens and induction of graft-versus-malignancyR Champlin, I Khouri, S Kornblau, et al.
Leukemia & Lymphoma|August 1, 1994
Leukemia cutis in acute promyelocytic leukemia: report of three cases after treatment with all-trans retinoic acidS Giralt, S O'Brien, E Weeks, et al.
Pageof 18